Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 27, 2002

View Archived Issues

New melanocortin agonists in early development at Lilly

BMS researchers synthesize novel antiamyloidogenic agents

Rigel and Daiichi team up for cancer drug discovery

EluSys receives funding for anthrax Heteropolymer

Alfacell expands Onconase research collaboration with NCI

Restructuring at Insmed to advance most promising drug candidates

DACH-platinum compound compares favorably with currently marketed platinum compounds

Oral and parenteral formulations of Vfend now available for serious fungal infections

Advisory committee review of Fabry's disease products delayed

Vardenafil: phase III clinical data discussed at congress, trade name selected

Update on phase II and III clinical studies of Theratope in breast cancer

Oral ZD-6474 inhibits VEGF-induced angiogenesis and tumor growth in mice

Safety of PS-341 demonstrated in patients with advanced solid tumors

ISIS-3521 and ISIS-5132 evaluated as single agents in HRPC

New data on the tolerability of LY-355703 in patients with refractory solid tumors

Pharmacokinetic data reported for extended-release metformin at recent meeting

Anticancer drug combination safe and effective against malignant pleural mesothelioma

Effect of BIM-44058 on trabecular microarchitecture in monkey model of postmenopausal osteoporosis

Noncalcemic vitamin D analogue inhibits prostate cancer cell growth and PTHrP gene expression

Toa Eiyo presents new agents for diabetes and lipoprotein disorders

LDL receptor upregulators covered by Takeda patent

New inhibitors of cell adhesion prepared and tested at Kowa

Roche describes synthesis, biological activity and potential uses of CDK2 inhibitors

G17DT granted fast track status for pancreatic cancer

Bone loss in inflammatory arthritis prevented by CLX-0921 and etanercept

Marketing approval sought in E.U. for triple combination Parkinson's therapy

Enrollment and treatment completed in phase I/II trial of DTI-015 in brain cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...